MetLife (NYSE:MET – Get Free Report) is projected to post its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $2.38 per share and revenue of $31.4313 billion for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 5, 2026 at 9:00 AM ET.
MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.07. The firm had revenue of $12.46 billion during the quarter, compared to analyst estimates of $18.64 billion. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The business’s revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the business earned $1.95 EPS. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.
MetLife Stock Performance
Shares of NYSE:MET opened at $79.86 on Tuesday. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife has a 12 month low of $65.21 and a 12 month high of $87.39. The company has a market capitalization of $52.62 billion, a price-to-earnings ratio of 15.04, a PEG ratio of 0.75 and a beta of 0.76. The firm’s 50-day moving average is $78.86 and its 200 day moving average is $78.84.
MetLife Dividend Announcement
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on MET. Mizuho set a $102.00 price target on MetLife in a research note on Wednesday, January 14th. Morgan Stanley set a $101.00 target price on MetLife and gave the stock an “overweight” rating in a research note on Monday, December 15th. Weiss Ratings reissued a “buy (b-)” rating on shares of MetLife in a research note on Monday, December 29th. UBS Group cut their price target on shares of MetLife from $95.00 to $94.00 and set a “buy” rating on the stock in a report on Thursday, January 8th. Finally, Barclays set a $90.00 price objective on shares of MetLife in a report on Thursday, January 8th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, MetLife currently has a consensus rating of “Buy” and a consensus target price of $95.27.
Get Our Latest Stock Report on MetLife
Hedge Funds Weigh In On MetLife
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Clark Capital Management Group Inc. raised its stake in MetLife by 4.8% in the third quarter. Clark Capital Management Group Inc. now owns 3,175 shares of the financial services provider’s stock worth $262,000 after buying an additional 145 shares in the last quarter. Tocqueville Asset Management L.P. increased its holdings in shares of MetLife by 0.6% in the 3rd quarter. Tocqueville Asset Management L.P. now owns 26,071 shares of the financial services provider’s stock valued at $2,147,000 after acquiring an additional 156 shares during the period. Triumph Capital Management lifted its stake in shares of MetLife by 4.8% during the 3rd quarter. Triumph Capital Management now owns 3,570 shares of the financial services provider’s stock worth $294,000 after purchasing an additional 164 shares during the last quarter. Nicolet Advisory Services LLC boosted its position in MetLife by 4.2% during the third quarter. Nicolet Advisory Services LLC now owns 4,719 shares of the financial services provider’s stock valued at $391,000 after purchasing an additional 190 shares in the last quarter. Finally, Evergreen Capital Management LLC grew its stake in MetLife by 2.0% in the second quarter. Evergreen Capital Management LLC now owns 10,726 shares of the financial services provider’s stock valued at $863,000 after purchasing an additional 214 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Featured Articles
- Five stocks we like better than MetLife
- The day the gold market broke
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
